The story of human cytomegalovirus and cancer: increasing evidence and open questions.
暂无分享,去创建一个
[1] C. Cobbs,et al. Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection , 2008, Nature.
[2] M. Birrer,et al. Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer. , 2008, Neoplasia.
[3] Evan T. Keller,et al. Type I collagen receptor (α2β1) signaling promotes prostate cancer invasion through RhoC GTPase , 2008 .
[4] T. Cloughesy,et al. Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. , 2008, The New England journal of medicine.
[5] E. Petty,et al. Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint. , 2008, Neoplasia.
[6] R. Khosravi‐Far,et al. Dysregulation of apoptotic signaling in cancer: Molecular mechanisms and therapeutic opportunities , 2008, Journal of cellular biochemistry.
[7] M. Zöller,et al. Tumorigenicity of IL-1α– and IL-1β–Deficient Fibrosarcoma Cells , 2008 .
[8] D. Coen,et al. Phosphorylation of Retinoblastoma Protein by Viral Protein with Cyclin-Dependent Kinase Function , 2008, Science.
[9] K. O’Connor,et al. Integrin α6β4 Promotes Migration, Invasion through Tiam1 Upregulation, and Subsequent , 2008 .
[10] Richard D. Smith,et al. Human Cytomegalovirus Secretome Contains Factors That Induce Angiogenesis and Wound Healing , 2008, Journal of Virology.
[11] B. Chait,et al. Human cytomegalovirus protein UL38 inhibits host cell stress responses by antagonizing the tuberous sclerosis protein complex. , 2008, Cell host & microbe.
[12] R. Youle,et al. Cytomegalovirus Proteins vMIA and m38.5 Link Mitochondrial Morphogenesis to Bcl-2 Family Proteins , 2008, Journal of Virology.
[13] G. L. Bentz,et al. Human CMV infection of endothelial cells induces an angiogenic response through viral binding to EGF receptor and β1 and β3 integrins , 2008, Proceedings of the National Academy of Sciences.
[14] D. Sheppard,et al. Induction of an epithelial integrin alphavbeta6 in human cytomegalovirus-infected endothelial cells leads to activation of transforming growth factor-beta1 and increased collagen production. , 2008, The American journal of pathology.
[15] K. Aldape,et al. Detection of human cytomegalovirus in different histological types of gliomas , 2008, Acta Neuropathologica.
[16] C. Söderberg-Nauclér. HCMV microinfections in inflammatory diseases and cancer. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[17] T. Mikkelsen,et al. FK506 binding protein mediates glioma cell growth and sensitivity to rapamycin treatment by regulating NF-kappaB signaling pathway. , 2008, Neoplasia.
[18] P. Tomasec,et al. Modulation of natural killer cells by human cytomegalovirus. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[19] J. Sinclair. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[20] R. McLendon,et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. , 2008, Neuro-oncology.
[21] C. Cobbs,et al. Modulation of oncogenic phenotype in human glioma cells by cytomegalovirus IE1-mediated mitogenicity. , 2008, Cancer research.
[22] J. L. Stern,et al. Immunomodulatory Properties of a Viral Homolog of Human Interleukin-10 Expressed by Human Cytomegalovirus during the Latent Phase of Infection , 2008, Journal of Virology.
[23] J. A. Nelson. Small RNAs and large DNA viruses. , 2007, The New England journal of medicine.
[24] M. Luo,et al. Long-Term Infection and Shedding of Human Cytomegalovirus in T98G Glioblastoma Cells , 2007, Journal of Virology.
[25] C. Cobbs,et al. Human cytomegalovirus induces cellular tyrosine kinase signaling and promotes glioma cell invasiveness , 2007, Journal of Neuro-Oncology.
[26] G. Wilkinson,et al. Complex I Binding by a Virally Encoded RNA Regulates Mitochondria-Induced Cell Death , 2007, Science.
[27] T. Shenk,et al. Human Cytomegalovirus UL38 Protein Blocks Apoptosis , 2007, Journal of Virology.
[28] D. Jonas,et al. Human cytomegalovirus infection alters PC3 prostate carcinoma cell adhesion to endothelial cells and extracellular matrix. , 2006, Neoplasia.
[29] Rob Leurs,et al. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis , 2006, Proceedings of the National Academy of Sciences.
[30] M. Fons,et al. Cytomegalovirus‐enhanced induction of chromosome aberrations in human peripheral blood lymphocytes treated with potent genotoxic agents , 2006, Environmental and molecular mutagenesis.
[31] C. Jefford,et al. Mechanisms of chromosome instability in cancers. , 2006, Critical reviews in oncology/hematology.
[32] G. Lip,et al. Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer. , 2006, Neoplasia.
[33] G. Christofori,et al. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment , 2006, Cellular and Molecular Life Sciences CMLS.
[34] V. Kim,et al. Downregulation of GFAP, TSP‐1, and p53 in human glioblastoma cell line, U373MG, by IE1 protein from human cytomegalovirus , 2005, Glia.
[35] H. Doerr,et al. Role of tumor cell immune escape mechanisms in cytomegalovirus‐mediated oncomodulation , 2005, Medicinal research reviews.
[36] Yoon-Jae Song,et al. Inhibition of Cell Division by the Human Cytomegalovirus IE86 Protein: Role of the p53 Pathway or Cyclin-Dependent Kinase 1/Cyclin B1 , 2005, Journal of Virology.
[37] H. Doerr,et al. Impact of persistent cytomegalovirus infection on human neuroblastoma cell gene expression. , 2005, Biochemical and biophysical research communications.
[38] D. Jonas,et al. Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness. , 2004, Neoplasia.
[39] L. Juan,et al. HCMV IE2‐mediated inhibition of HAT activity downregulates p53 function , 2004, The EMBO journal.
[40] H. Doerr,et al. Cytomegalovirus infection blocks apoptosis in cancer cells , 2004, Cellular and Molecular Life Sciences CMLS.
[41] E. Hwang,et al. Human Cytomegalovirus (HCMV) Infection in Osteosarcoma Cell Line Suppresses GM‐CSF Production by Induction of TGF‐β , 2004, Microbiology and immunology.
[42] Jindrich Cinatl,et al. Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression. , 2004, FEMS microbiology reviews.
[43] T. Kowalik,et al. HCMV INFECTION: MODULATING THE CELL CYCLE AND CELL DEATH , 2004, International reviews of immunology.
[44] P. Casarosa,et al. Human Cytomegalovirus Chemokine Receptor US28-induced Smooth Muscle Cell Migration Is Mediated by Focal Adhesion Kinase and Src* , 2003, Journal of Biological Chemistry.
[45] P. Barry,et al. Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. , 2003, Virology.
[46] C. Cobbs,et al. High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. , 2003, The Journal of urology.
[47] H. Kellner,et al. [Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer]. , 2003, Zeitschrift fur Gastroenterologie.
[48] D. Caput,et al. Human Cytomegalovirus Induces Drug Resistance and Alteration of Programmed Cell Death by Accumulation of ΔN-p73α* , 2002, The Journal of Biological Chemistry.
[49] C. Cobbs,et al. Human cytomegalovirus infection and expression in human malignant glioma. , 2002, Cancer research.
[50] T. Schall,et al. Potent Immunosuppressive Activities of Cytomegalovirus- Encoded Interleukin-10 , 2002, Journal of Virology.
[51] T. Chittenden,et al. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[52] K. Matsushima,et al. The immediate early gene 1 product of human cytomegalovirus is sufficient for up-regulation of interleukin-8 gene expression. , 2000, Biochemical and biophysical research communications.
[53] M. Stinski,et al. The Human Cytomegalovirus IE86 Protein Can Block Cell Cycle Progression after Inducing Transition into the S Phase of Permissive Cells , 2000, Journal of Virology.
[54] M. Kasten,et al. Cell cycle and apoptosis. , 2000, Neoplasia.
[55] T. Shenk,et al. Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[56] S. Pestka,et al. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[57] M. Dell'aquila,et al. Specific chromosome 1 breaks induced by human cytomegalovirus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[58] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[59] Cecilia Soderberg-Naucler,et al. The Human Cytomegalovirus Chemokine Receptor US28 Mediates Vascular Smooth Muscle Cell Migration , 1999, Cell.
[60] E. Kieff,et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[61] M. Smyth,et al. M144, a Murine Cytomegalovirus (Mcmv)-Encoded Major Histocompatibility Complex Class I Homologue, Confers Tumor Resistance to Natural Killer Cell–Mediated Rejection , 1999, The Journal of experimental medicine.
[62] H. Doerr,et al. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53. , 1999, The American journal of pathology.
[63] J. Doniger,et al. Human Cytomegalovirus and Human Herpesvirus 6 Genes That Transform and Transactivate , 1999, Clinical Microbiology Reviews.
[64] V. Ferrans,et al. Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. , 1999, Circulation.
[65] J. Alwine,et al. Effects of Human Cytomegalovirus Major Immediate-Early Proteins in Controlling the Cell Cycle and Inhibiting Apoptosis: Studies with ts13 Cells , 1999, Journal of Virology.
[66] H. Doerr,et al. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. , 1998, Cancer research.
[67] K. Matsushima,et al. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line, THP-1, through acting concurrently on AP-1- and NF-kappaB-binding sites of the interleukin-8 gene , 1997, Journal of virology.
[68] T. Shenk,et al. Human Cytomegalovirus IE1 and IE2 Proteins are Mutagenic and Mediate ``Hit-And-Run" Oncogenic Transformation in Cooperation with the Adenovirus E1A Proteins , 1997 .
[69] G. Hayward,et al. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site , 1996, Journal of virology.
[70] G. Kou,et al. Human Cytomegalovirus Immediate-Early Protein IE2 Tethers a Transcriptional Repression Domain to p53 (*) , 1996, The Journal of Biological Chemistry.
[71] H. Doerr,et al. Long‐term productive human cytomegalovirus infection of a human neuroblastoma cell line , 1996, International journal of cancer.
[72] T. Shenk,et al. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. , 1995, Journal of virology.
[73] D. Ramsay,et al. Cytogenetic evidence that a tumor suppressor gene in the long arm of chromosome 1 contributes to glioma growth. , 1995, Cancer genetics and cytogenetics.
[74] L. Picard,et al. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor beta 1 , 1994, Journal of virology.
[75] M. Leon,et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. , 1994, Science.
[76] C. Payá,et al. Antagonistic modulation of human cytomegalovirus replication by transforming growth factor beta and basic fibroblastic growth factor. , 1993, The Journal of general virology.
[77] M. Fons,et al. Modulation of the frequency of human cytomegalovirus-induced chromosome aberrations by camptothecin. , 1992, Virology.
[78] J. Sissons,et al. Human cytomegalovirus infection. , 1989, Thorax.
[79] H. Sato,et al. Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics. , 1986, The Journal of general virology.
[80] T. Furukawa. A variant of human cytomegalovirus derived from a persistently infected culture. , 1984, Virology.
[81] D. Galloway,et al. Structure of the transforming region of human cytomegalovirus AD169 , 1984, Journal of virology.
[82] F. Rapp,et al. Human cells transformed in vitro by human cytomegalovirus: tumorigenicity in athymic nude mice. , 1977, Journal of the National Cancer Institute.
[83] F. Rapp,et al. Oncogenic transformation of human embryo lung cells by human cytomegalovirus. , 1976, Science.
[84] M. Hartmann,et al. Chromosome aberrations in cytomegalovirus-infected human diploid cell culture. , 1972, Acta virologica.
[85] D. Spector,et al. Subversion of cell cycle regulatory pathways. , 2008, Current topics in microbiology and immunology.
[86] K. Früh,et al. Cytomegalovirus immune evasion. , 2008, Current topics in microbiology and immunology.
[87] Z. Cruz-Monserrate,et al. Integrin alpha 6 beta 4 promotes migration, invasion through Tiam1 upregulation, and subsequent Rac activation. , 2008, Neoplasia.
[88] M. Zöller,et al. Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells. , 2008, Neoplasia.
[89] A. McCormick. Control of apoptosis by human cytomegalovirus. , 2008, Current topics in microbiology and immunology.
[90] E. Jaffee,et al. Mechanisms of immune evasion by tumors. , 2006, Advances in immunology.
[91] M. Weller,et al. Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. , 2006, Current pharmaceutical design.
[92] H. Doerr,et al. Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology. , 2004, Trends in molecular medicine.
[93] E. Fortunato,et al. Viral induction of site‐specific chromosome damage , 2003, Reviews in medical virology.
[94] D. Caput,et al. Human cytomegalovirus induces drug resistance and alteration of programmed cell death by accumulation of deltaN-p73alpha. , 2002, The Journal of biological chemistry.
[95] J. Rak,et al. The hemostatic system and angiogenesis in malignancy. , 2001, Neoplasia.
[96] A. Mares,et al. HIT AND RUN , 1999 .
[97] J. Vogel,et al. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. , 1996, Intervirology.
[98] I. Bièche,et al. Loss and gain of distinct regions of chromosome 1q in primary breast cancer. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[99] T. Albrecht,et al. Alteration in the coding potential and expression of H-ras in human cytomegalovirus-transformed cells. , 1994, Intervirology.
[100] H. Herzog,et al. Fluorescence in situ mapping of the human nuclear NAD+ ADP-ribosyltransferase gene (ADPRT) and two secondary sites to human chromosomal bands 1q42, 13q34, and 14q24. , 1992, Cytogenetics and cell genetics.
[101] F. Rapp,et al. Alterations in biological properties of different lines of cytomegalorivus-transformed human embryo lung cells following in vitro cultivation. , 1978, IARC scientific publications.